- Summary
- Price Reports
- Price History
- Add To Your Stocklist
- View your Stocklist
- Basic Chart
- Interactive Chart
- Headlines (24h)
- Company Snapshot
- Summary Reports
- Free Annual Report
- Estimate Snapshot
- Estimate Report
- Mobile Quote
- Real-Time Quote
- Streaming Quote
|
Mylan Inc. | Company Snapshot
-
![]()
-
-
-
Vol:
-
Last Trade:
|
MYLAN INC.
Mylan Inc. is one of the world's leading quality generic and specialty pharmaceutical companies. The Company offers one of the industry's broadest and highest quality product portfolios, a robust product pipeline and a global commercial footprint through operations in more than 90 countries. Through its controlling interest in Matrix Laboratories Limited, Mylan has direct access to one of the largest active pharmaceutical ingredient manufacturers in the world. Dey L.P., Mylan's fully integrated specialty business, provides the Company with innovative and diversified opportunities in the respiratory and allergy therapeutic areas.
|
|
| Symbol: |
MYL |
| Exchange(s): |
Nasdaq Stock Market |
| Industry: |
Consumer Products (Biotechnology & Pharmaceuticals) |
| 5-Star Rating: |
 |
|
ANNUAL FINANCIALS
|
|
|
Dec 31, 2008
12 Months
us$
|
Dec 31, 2007
12 Months
us$
|
Dec 31, 2006
12 Months
us$
|
3Yr.
Growth
% Change
|
|
Total Revenue ($000)
|
5,137,580
|
2,666,020
|
401,760
|
154.62
|
|
Earnings before Interest & Tax ($000)
|
309,220
|
N/A
|
216,070
|
55.30
|
|
Profit/Loss ($000)
|
-181,210
|
-1,209,310
|
135,440
|
N/A
|
|
Earnings per Share
|
-1.05
|
-4.91
|
1.01
|
N/A
|
|
Total Assets ($000)
|
10,409,860
|
N/A
|
2,206,640
|
78.35
|
|
Dividends Per Share
|
0.00
|
0.12
|
0.24
|
|
|
Return on Com. Equity
|
N/A
|
N/A
|
14.55
|
|
|
Employees
|
N/A
|
N/A
|
N/A
|
|
|
|
|
|
Trailing 12 Month Results
|
|
|
12 Months ended
Dec 31, 2009,us$
|
12 Months ended
Dec 31, 2008,us$
|
%Change
|
|
Total Revenue ($000)
|
N/A
|
5,137,590
|
N/A
|
|
Profit/Loss ($000)
|
N/A
|
-181,210
|
N/A
|
|
Earnings per Share
|
N/A
|
-1.06
|
N/A
|
|
Dividends Per Share
|
0.00
|
0.00
|
|
Number of Shares
|
305,580,000
|
304,700,000
|
|
|
|
|
|
COMPANY INFORMATION
|
| Key Personnel |
| CEO: Milan Puskar, Chmn.; Dir. |
| CFO: Robert J. Coury, Vice-Chmn.; C.E.O.; Dir. |
| |
| Contact Information |
| Address: |
1500 Corporate Drive,
Canonsburg,
PA,
15317 |
Phone: |
724-514-1800 |
| Web Address: |
www.mylan.com |
| E-Mail : |
investor_relations@mylan.com |
| |
| Incorporation:
| United States |
| |
|
Securities:
|
MYL-Q MYLNG-Q MYLNP-Q
|
|
| |
|
|
| |
|
|
Financial data is provided by Zacks Investment Research.
| |
All information on this site is compiled by CTVglobemedia Publishing Inc. from reliable industry sources. While all efforts are made to ensure the accuracy of the information, CTVglobemedia Publishing Inc. and its related entities assume no liability for incorrect, incomplete, or missing information from this site. Past performance is not necessarily indicative of future performance. Prior to making any investment decision, consult with a qualified investment advisor.
Copyright © 2010 CTVglobemedia Publishing Inc. All rights reserved.
|
|
|
